Holocene Advisors’s Cardiovascular Systems, Inc. CSII Stock Holding History

Holocene Advisors’s Portfolio CSII Stock Details CSII Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-41,679	Closed	-$1.6M	–	966
2021 Q1	$1.6M	Buy	41,679 +20,828	+100%	+$887K	0.01%	632
2020 Q4	$912K	Buy	20,851 +15,123	+264%	+$569K	0.01%	563
2020 Q3	$225K	Sell	5,728 -144,272	-96%	-$4.66M	﹤0.01%	637
2020 Q2	$4.73M	Buy	+150,000	New	+$5.6M	0.04%	212
2020 Q1	–	Sell	-23,217	Closed	-$1.13M	–	859
2019 Q4	$1.13M	Buy	23,217 +17,607	+314%	+$802K	0.01%	538
2019 Q3	$267K	Buy	+5,610	New	+$264K	﹤0.01%	655
2018 Q4	–	Sell	-14,694	Closed	-$575K	–	886
2018 Q3	$575K	Buy	+14,694	New	+$543K	0.01%	504

Other funds holding CSII

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

BCM

Brown Capital Management Baltimore, Maryland $500M AUM 25.3% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $3.89B AUM 16.15% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

RGM Capital Naples, Florida $2.06B AUM 8.49% 1-Year Est. Return

Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return

Holocene Advisors's CSII Position: Q2 2021 in Review

Holocene Advisors sold out of Cardiovascular Systems, Inc. (CSII) in Q2 2021, closing a stake of 41,679 shares — an estimated $1.6M sold.

Holocene Advisors first reported a position in CSII in Q3 2018 and held it in 7 quarters. The position peaked at $4.73M in Q2 2020. 173 funds tracked by Wall St. Rank hold CSII as of Q2 2021.

Holocene Advisors reported no remaining Cardiovascular Systems, Inc. position as of Q2 2021 after selling out during the quarter.
Holocene Advisors sold 41,679 Cardiovascular Systems, Inc. shares in Q2 2021, an estimated $1.6M.
Holocene Advisors first reported a position in Cardiovascular Systems, Inc. in Q3 2018 and held it in 7 quarters.
Holocene Advisors's Cardiovascular Systems, Inc. position peaked at $4.73M in Q2 2020.
173 funds tracked by Wall St. Rank held Cardiovascular Systems, Inc. as of Q2 2021.

Based on Holocene Advisors's 13F filing for Q2 2021, filed 16 Aug 2021.